Maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the United States

被引:20
作者
Abbott, KC [1 ]
Koff, J
Bohen, EM
Oglesby, RJ
Agodoa, LYC
Lentine, KL
Schnitzler, MA
机构
[1] Walter Reed Army Med Ctr, Serv Nephrol, Washington, DC 20307 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[3] Walter Reed Army Med Ctr, Serv Gastroenterol, Washington, DC 20307 USA
[4] Walter Reed Army Med Ctr, Rheumatol Serv, Washington, DC 20307 USA
[5] NIDDK, NIH, Bethesda, MD USA
[6] St Louis Univ, Sch Med, Ctr Outcomes Res, St Louis, MO USA
关键词
avascular necrosis; medicare claim; renal transplant; female; peritoneal dialysis; cyclosporine A; tacrolimus; US renal database system;
D O I
10.1097/01.TP.0000149894.95435.7F
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Avascular necrosis (AVN) after renal transplantation has been largely attributed to the use of corticosteroids. However, other risk factors such as microvascular thrombosis and hyperlipidemia have been well described and may be of increased importance in the era of early steroid cessation and avoidance. We hypothesized that maintenance immunosuppressive medications known to be associated with these risk factors for AVN would also be associated with a higher risk of AVN. Methods. By using the U.S. Renal Data System database, we studied 27,772 primary patients on Medicare who received a solitary kidney transplant between January 1, 1996, and July 31, 2000. Cox proportional hazards regression models were used to calculate adjusted hazard ratios (AHRs) for patient- and transplant-related factors (including allograft rejection) with Medicare claims for AVN. The intensity and duration of corticosteroid use could not be assessed. Results. Among patients who were prescribed sirolimus at discharge, 3.5% of patients who received the combination of sirolimus-cyclosporine A (CsA) demonstrated AVN, compared with 1.4% of patients who received the combination of siroli-mus-tacrolimus (P=0.06 by chi(2)). In Cox regression, CsA use (vs. tacrolimus) (AHR 1.36, 95% confidence interval, 1.09-1.71) was independently associated with an increased risk of AVN. Sirolimus use showed a trend toward significance (AHR 1.59, 95% confidence interval, 0.99-2.56), with no significant interaction with CsA. Conclusions. Compared with other maintenance immunosuppression, AVN was significantly more common after use of CsA prescribed at the time of discharge for renal transplantation. Whether this increased risk of AVN was directly attributable to hyperlipidemia, microvascular thrombosis, or differences in corticosteroid dosing could not be determined.
引用
收藏
页码:330 / 336
页数:7
相关论文
共 46 条
[1]   Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States [J].
Abbott, KC ;
Cruess, DF ;
Agodoa, LYC ;
Sawyers, ES ;
Tveit, DP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (01) :120-130
[2]   Hospitalized avascular necrosis after renal transplantation in the United States [J].
Abbott, KC ;
Oglesby, RJ ;
Agodoa, LY .
KIDNEY INTERNATIONAL, 2002, 62 (06) :2250-2256
[3]   Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects [J].
Asano, T ;
Takahashi, KA ;
Fujioka, M ;
Inoue, S ;
Ueshima, K ;
Hirata, T ;
Okamoto, M ;
Satomi, Y ;
Nishino, H ;
Tanaka, T ;
Hirota, Y ;
Kubo, T .
TRANSPLANTATION, 2004, 77 (02) :220-225
[4]  
Asano Takeshi, 2003, Pharmacogenetics, V13, P675, DOI 10.1097/00008571-200311000-00003
[5]  
Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724
[6]  
Berger CE, 2002, CLIN ORTHOP RELAT R, P342
[7]   Premature osteonecrosis and sirolimus treatment in renal transplantation [J].
Bhandari, S ;
Eris, J .
BRITISH MEDICAL JOURNAL, 2001, 323 (7314) :665-665
[8]   Osteonecrosis of the femoral head of laboratory animals: The lessons learned from a comparative study of osteonecrosis in man and experimental animals [J].
Boss, JH ;
Misselevich, I .
VETERINARY PATHOLOGY, 2003, 40 (04) :345-354
[9]   Hospitalizations for total hip arthroplasty after renal transplantation in the United States [J].
Bucci, JR ;
Oglesby, RJ ;
Agodoa, LY ;
Abbott, KC .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (10) :999-1004
[10]   A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (Neoral) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year [J].
Ciancio, G ;
Burke, GW ;
Gaynor, JJ ;
Mattiazzi, A ;
Roth, D ;
Kupin, W ;
Nicolas, M ;
Ruiz, P ;
Rosen, A ;
Miller, J .
TRANSPLANTATION, 2004, 77 (02) :244-251